Veterinary vaccination strategies are often operationalized through predefined products, schedules, target populations, and coverage objectives, yet the biological and epidemiological conditions that originally justified those choices may change. Antigenic evolution can alter vaccine–field strain relationships; immunity can decline or be diluted by population turnover; age, maternal immunity, species, and production structure can modify vaccine responses; exposure may be spatially or demographically concentrated; and clinically meaningful protection may not parallel reduction in infection or shedding. This article develops an original non-empirical adaptive vaccination framework for interpreting these changes without assuming that every surveillance signal warrants immediate strategy modification. The framework separates pathogen change, population immunity, host structure, exposure heterogeneity, disease consequence, vaccine performance, duration of protection, vaccine–field strain match, and operational feasibility before these domains are jointly adjudicated. It further distinguishes booster, reformulation, and targeting decisions rather than treating adaptation as a single intervention. The proposed approach emphasizes noncompensatory constraints: strong performance in one domain should not automatically negate major deficiencies in another, and biological desirability does not establish operational feasibility. Surveillance is therefore positioned as a trigger for structured reassessment rather than as an automatic mandate for action. The framework is intended to improve conceptual consistency in veterinary vaccination decision-making, but it is not a prospectively validated prediction rule, universal schedule, or implementation standard. Its usefulness will depend on disease-specific measurements, locally relevant surveillance, endpoint-specific vaccine evaluation, and external validation across species, production systems, and epidemiological settings.
